Concerns over informed consent for pregnant women in Pfizer’s RSV vaccine trial-Reference-Cited by-同舟云学术

Concerns over informed consent for pregnant women in Pfizer’s RSV vaccine trial

Published:2023-11-15 Issue: Volume: Page:p2620
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Boytchev Hristio

Publisher

BMJ

Subject

Industrial and Manufacturing Engineering,Metals and Alloys,Strategy and Management,Mechanical Engineering

Reference13 articles.

1. GSK. GSK provides further update on phase III RSV maternal vaccine candidate programme. 28 February 2022. www.gsk.com/en-gb/media/press-releases/gsk-provides-further-update-on-phase-iii-rsv-maternal-vaccine-candidate-programme

2. GSK. Sponsor briefing document. Vaccines and related biological products advisory committee. 2Feb/Mar 2023. http://www.fda.gov/media/165621/download#page=42

3. ReSViNET Foundation. Resvinet Conference 2023 Day 2. Youtube. www.youtube.com/watch?v=P45AbqFeYBY&t=28346s

4. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

5. US Food and Drug Administration. Vaccines and related biological products advisory committee. https://www.fda.gov/media/168185/download

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Vaccines;2024-05-05

2. Safety of RSV Vaccine among Pregnant Individuals: A Real-World Pharmacovigilance Study Using Vaccine Adverse Event Reporting System;2024-04-25

3. RSV vaccines administered in error to infants and pregnant people, CDC reports;BMJ;2024-01-29